Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$29,119,437
+$559,801 QoQ
Shares Held
114,657
-1.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
#604
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$24,444
PutShares
100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arkadios Wealth Advisors holds $175,268,765 across 14 Drug Manufacturers - General names. JNJ ranks #2 (16.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
32,277 | $38,714,004 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
114,657 | $29,119,437 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
320,925 | $18,491,698 | |
| 4 | MRK |
Merck & Co., Inc.
|
140,968 | $18,114,387 | |
| 5 | ABBV |
AbbVie Inc.
|
65,660 | $16,522,681 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
104,200 | $13,164,627 | |
| 7 | PFE |
Pfizer Inc
|
411,666 | $9,912,916 | |
| 8 | AMGN |
Amgen Inc
|
26,885 | $9,735,596 |
All Filings in JNJ
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,119,437 | 114,657 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $28,559,636 | 116,837 | Shares | Sole | 2026-05-18 | |
| 2026-03-31 | $24,444 | 100 | Put | Sole | 2026-05-18 | |
| 2025-12-31 | $23,313,951 | 112,655 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $14,753,127 | 79,566 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $11,461,137 | 75,032 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $10,087,715 | 60,828 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $6,680,287 | 46,192 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $9,961,342 | 61,467 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $13,367,501 | 91,458 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $12,637,008 | 79,885 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $12,069,606 | 77,004 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $11,202,318 | 71,925 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $7,717,701 | 46,627 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $7,177,120 | 46,304 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $7,619,621 | 43,134 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $6,422,171 | 39,313 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $6,084,510 | 34,277 | Shares | Sole | 2022-07-14 | |
| 2022-03-31 | $5,683,234 | 32,067 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $4,329,952 | 25,311 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $3,640,856 | 22,544 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $4,062,817 | 24,662 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $3,783,501 | 23,021 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $2,441,750 | 15,515 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,147,567 | 7,708 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,111,539 | 7,904 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $968,132 | 7,383 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||